在接受免疫球蛋白替代疗法的原发性免疫缺陷患者中,针对呼吸道病原体的疫苗接种

Makbule Seda Bayrak Durmaz1, Reyhan Yıldız1, Göksal Keskin1

  • 1Division of Immunology and Allergy, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.

Tuberkuloz ve toraks
|April 27, 2024
PubMed
概括

接种疫苗对于患有天生的免疫缺陷 (IEI) 患者至关重要. 这项研究发现,在接受免疫球蛋白替代疗法 (IGRT) 的IEI患者中,COVID-19疫苗接种率更高,强调个性化疫苗决定.

相关概念视频

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
72.6K
Vaccinations01:51

Vaccinations

Overview
44.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
936
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
305
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136